Alliance A222004: A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia

Objective

This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine may stimulate and increase appetite. This study aims to find out if olanzapine is better than the usual approach (megestrol acetate) for stimulating appetite and preventing weight loss.

https://clinicaltrials.gov/ct2/show/NCT04939090

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Research Studies

Specialties

• Brain Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Genitourinary Cancer
• Gynecologic Cancer
• Head and Neck Cancer
• Hematology
• Lung Cancer
• Rare Tumor
• Sarcoma
• Skin Cancer

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]